Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
A recurring theme at G2's 35th annual Lab Institute conference (Washington D.C.; Oct. 25-27) was the central role laboratory data can play…
From - Diagnostic Testing & Emerging Technologies
Recent cervical cancer screening guideline changes are associated with reduced chlamydia testing, particularly among women aged 15 to 19 years, who are…
From - Diagnostic Testing & Emerging Technologies
Routine annual tuberculosis (TB) screening of health care workers is no longer cost effective, according to a study published May 17 in BMC Medicine. The incidence of…
From - Diagnostic Testing & Emerging Technologies
The power of celebrity impacts health decisions and drives testing decisions beyond the "Angelina Jolie effect." A study published in the…